Latest News

SHANGHAI, China — Dizal Pharmaceutical today announced that the results of a phase 2 pivotal study of sunvozertinib for the treatment of platinum-pretreated non-small-cell lung cancer (NSCLC) patients with EGFR exon 20 insertion mutations (exon20ins) (WU-KONG6) were published in the peer-reviewed journal The Lancet Respiratory Medicine. The publication of these...
Umeå, Sweden – A pioneering study at Umeå University, Sweden, has unveiled that the 3D organization of DNA can influence the progression of the aggressive brain tumour known as glioblastoma. Having identified the factors that glioblastoma uses to respond to neurons by growing and spreading, this discovery paves the way...
Hoboken, New Jersey – New research indicates that individuals with persistent and worsening metabolic syndrome—which encompasses conditions such as high blood pressure, elevated blood sugar, excess abdominal fat, and abnormal cholesterol—face an elevated risk of developing various types of cancer. The findings are published by Wiley online in CANCER, a...
Dogs always have been known as man’s best friend, but when it comes to seizure-response dogs for those with epilepsy, these special canines become invaluable protectors. The Walker family in north suburban Grayslake — mom Candace and children Colin, 11, Carson, 9, and Cailean, 5 — know this all too...
POWAY — A Poway man afflicted with a life-threatening skin disease has passed a major obstacle on his way to an experimental stem-cell treatment. Mark Buenconsejo, 51, already has raised money with fundraisers and has successfully fought an insurance company that originally had refused to cover the expenses for a...
STAMFORD, Conn. – Dr. James M. Wilson and Alex Karnal announced today the launch of The Institute for Life Changing Medicines, a nonprofit organization, with a mission of identifying, developing and promoting access to therapies that have transformative potential but are not considered commercially viable because they are designed to...